<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00168155</url>
  </required_header>
  <id_info>
    <org_study_id>CPTAIV-0020-357</org_study_id>
    <nct_id>NCT00168155</nct_id>
  </id_info>
  <brief_title>Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma</brief_title>
  <official_title>Phase 2 Study of Neoadjuvant 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alberta Health Services</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>AHS Cancer Control Alberta</source>
  <brief_summary>
    <textblock>
      When colon or rectal cancer has spread to the liver, the cancer in the liver can sometimes be&#xD;
      removed surgically. However, the cancer has a chance or reoccurring in the liver or elsewhere&#xD;
      in the body. This study will determine if giving chemotherapy treatment before the surgery&#xD;
      can reduce the chances that the cancer will come back.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      When colon or rectal cancer has spread to the liver, the cancer in the liver can sometimes be&#xD;
      removed surgically. However, the cancer has a chance or reoccurring in the liver or elsewhere&#xD;
      in the body. This study will determine if giving chemotherapy treatment before the surgery&#xD;
      can reduce the chances that the cancer will come back.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2002</start_date>
  <completion_date type="Actual">May 2009</completion_date>
  <primary_completion_date type="Actual">May 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>disease free survival</measure>
  </primary_outcome>
  <enrollment>70</enrollment>
  <condition>Colorectal Adenocarcinoma</condition>
  <condition>Liver Metastases</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>perioperative chemotherapy</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  stage IV colorectal cancer isolated to the liver&#xD;
&#xD;
          -  one measurable lesion&#xD;
&#xD;
          -  metastases are completely resectable or amenable to ablation&#xD;
&#xD;
          -  Karnofsky &gt;70&#xD;
&#xD;
          -  Adequate bone marrow function&#xD;
&#xD;
          -  adequate hepatic function&#xD;
&#xD;
          -  adequate renal function&#xD;
&#xD;
          -  informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  primary tumor not controlled by locoregional treatments&#xD;
&#xD;
          -  bilateral portal vein and/or hepatic artery involvement&#xD;
&#xD;
          -  previous chemotherapy directed at treatment of metastatic colorectal cancer&#xD;
&#xD;
          -  underlying acute or chronic liver disease&#xD;
&#xD;
          -  Gilbert's disease&#xD;
&#xD;
          -  patients receiving phenytoin or phenobarbital prophylaxis&#xD;
&#xD;
          -  presence of any concurrent medical or psychiatric condition that serves as a&#xD;
             contraindication to surgery or chemotherapy&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  malignancy other than basal cell or squamous cell carcinoma of the skin within the&#xD;
             preceding 5 years&#xD;
&#xD;
          -  use of another investigational medication concurrently or within 4 months of&#xD;
             enrollment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oliver Bathe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alberta Health Services</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tom Baker Cancer Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 4N2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2011</verification_date>
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2005</study_first_posted>
  <last_update_submitted>January 18, 2012</last_update_submitted>
  <last_update_submitted_qc>January 18, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 19, 2012</last_update_posted>
  <keyword>resectable liver metastases</keyword>
  <keyword>colorectal adenocarcinoma</keyword>
  <keyword>survival</keyword>
  <keyword>neoadjuvant chemotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Neoplasms, Second Primary</mesh_term>
    <mesh_term>Liver Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

